What’s Killing Central Americans by the Thousands?

All that doctors can do at this point is speculate about the cause of thousands of unexplained deaths from a mystery disease.

Associated Press
February 11, 2012

Jesus Ignacio Flores started working when he was 16, laboring long hours on construction sites and in the fields of his country’s biggest sugar plantation.

Three years ago his kidneys started to fail and flooded his body with toxins. He became too weak to work, wracked by cramps, headaches and vomiting.

On Jan. 19 he died on the porch of his house. He was 51. His withered body was dressed by his weeping wife, embraced a final time, then carried in the bed of a pickup truck to a grave on the edge of Chichigalpa, a town in Nicaragua’s sugar-growing heartland, where studies have found more than one in four men showing symptoms of chronic kidney disease.

A mysterious epidemic is devastating the Pacific coast of Central America, killing more than 24,000 people in El Salvador and Nicaragua since 2000 and striking thousands of others with chronic kidney disease at rates unseen virtually anywhere else. Scientists say they have received reports of the phenomenon as far north as southern Mexico and as far south as Panama.

Last year it reached the point where El Salvador’s health minister, Dr. Maria Isabel Rodriguez, appealed for international help, saying the epidemic was undermining health systems.

Wilfredo Ordonez, who has harvested corn, sesame and rice for more than 30 years in the Bajo Lempa region of El Salvador, was hit by the chronic disease when he was 38. Ten years later, he depends on dialysis treatments he administers to himself four times a day.

“This is a disease that comes with no warning, and when they find it, it’s too late,” Ordonez said as he lay on a hammock on his porch.

Many of the victims were manual laborers or worked in sugar cane fields that cover much of the coastal lowlands. Patients, local doctors and activists say they believe the culprit lurks among the agricultural chemicals workers have used for years with virtually none of the protections required in more developed countries. But a growing body of evidence supports a more complicated and counterintuitive hypothesis.

The roots of the epidemic, scientists say, appear to lie in the grueling nature of the work performed by its victims, including construction workers, miners and others who labor hour after hour without enough water in blazing temperatures, pushing their bodies through repeated bouts of extreme dehydration and heat stress for years on end. Many start as young as 10. The punishing routine appears to be a key part of some previously unknown trigger of chronic kidney disease, which is normally caused by diabetes and high-blood pressure, maladies absent in most of the patients in Central America.

“The thing that evidence most strongly points to is this idea of manual labor and not enough hydration,” said Daniel Brooks, a professor of epidemiology at Boston University’s School of Public Health, who has worked on a series of studies of the kidney disease epidemic.

Because hard work and intense heat alone are hardly a phenomenon unique to Central America, some researchers will not rule out manmade factors. But no strong evidence has turned up.

“I think that everything points away from pesticides,” said Dr. Catharina Wesseling, an occupational and environmental epidemiologist who also is regional director of the Program on Work, Health and Environment in Central America. “It is too multinational; it is too spread out.

“I would place my bet on repeated dehydration, acute attacks everyday. That is my bet, my guess, but nothing is proved.”

Dr. Richard J. Johnson, a kidney specialist at the University of Colorado, Denver, is working with other researchers investigating the cause of the disease. They too suspect chronic dehydration.

“This is a new concept, but there’s some evidence supporting it,” Johnson said. “There are other ways to damage the kidney. Heavy metals, chemicals, toxins have all been considered, but to date there have been no leading candidates to explain what’s going on in Nicaragua …

“As these possibilities get exhausted, recurrent dehydration is moving up on the list.”

In Nicaragua, the number of annual deaths from chronic kidney disease more than doubled in a decade, from 466 in 2000 to 1,047 in 2010, according to the Pan American Health Organization, a regional arm of the World Health Organization. In El Salvador, the agency reported a similar jump, from 1,282 in 2000 to 2,181 in 2010.

Farther down the coast, in the cane-growing lowlands of northern Costa Rica, there also have been sharp increases in kidney disease, Wesseling said, and the Pan American body’s statistics show deaths are on the rise in Panama, although at less dramatic rates.

While some of the rising numbers may be due to better record-keeping, scientists have no doubt they are facing something deadly and previously unknown to medicine.

In nations with more developed health systems, the disease that impairs the kidney’s ability to cleanse the blood is diagnosed relatively early and treated with dialysis in medical clinics. In Central America, many of the victims treat themselves at home with a cheaper but less efficient form of dialysis, or go without any dialysis at all.

At a hospital in the Nicaraguan town of Chinandega, Segundo Zapata Palacios sat motionless in his room, bent over with his head on the bed.

“He no longer wants to talk,” said his wife, Enma Vanegas.

His levels of creatinine, a chemical marker of kidney failure, were 25 times the normal amount.

His family told him he was being hospitalized to receive dialysis. In reality, the hope was to ease his pain before his inevitable death, said Carmen Rios, a leader of Nicaragua’s Association of Chronic Kidney Disease Patients, a support and advocacy group.

“There’s already nothing to do,” she said. “He was hospitalized on Jan. 23 just waiting to die.”

Zapata Palacios passed away on Jan. 26. He was 49.

Working with scientists from Costa Rica, El Salvador and Nicaragua, Wesseling tested groups on the coast and compared them with groups who had similar work habits and exposure to pesticide but lived and worked more than 500 meters (1,500 feet) above sea level.

Some 30 percent of coastal dwellers had elevated levels of creatinine, strongly suggesting environment rather than agrochemicals was to blame, Brooks, the epidemiologist, said. The study is expected to be published in a peer-reviewed journal in coming weeks.

Brooks and Johnson, the kidney specialist, said they have seen echoes of the Central American phenomenon in reports from hot farming areas in Sri Lanka, Egypt and the Indian east coast.

“We don’t really know how widespread this is,” Brooks said. “This may be an under-recognized epidemic.”

Jason Glaser, co-founder of a group working to help victims of the epidemic in Nicaragua, said he and colleagues also have begun receiving reports of mysterious kidney disease among sugar cane workers in Australia.

Despite the growing consensus among international experts, Elsy Brizuela, a doctor who works with an El Salvadoran project to treat workers and research the epidemic, discounts the dehydration theory and insists “the common factor is exposure to herbicides and poisons.”

Nicaragua’s highest rates of chronic kidney disease show up around the Ingenio San Antonio, a plant owned by the Pellas Group conglomerate, whose sugar mill processes nearly half the nation’s sugar. Flores and Zapata Palacios both worked at the plantation.

According to one of Brooks’ studies, about eight years ago the factory started providing electrolyte solution and protein cookies to workers who previously brought their own water to work. But the study also found that some workers were cutting sugar cane for as long as 9 1/2 hours a day with virtually no break and little shade in average temperatures of 30 C (87 F).

In 2006, the plantation, owned by one of the country’s richest families, received $36.5 million in loans from the International Finance Corp., the private-sector arm of the World Bank Group, to buy more land, expand its processing plant and produce more sugar for consumers and ethanol production.

In a statement, the IFC said it had examined the social and environmental impacts of its loans as part of a due diligence process and did not identify kidney disease as something related to the sugar plantation’s operations.

Nonetheless, the statement said, “we are concerned about this disease that affects not only Nicaragua but other countries in the region, and will follow closely any new findings.”

Ariel Granera, a spokesman for the Pellas’ business conglomerate, said that starting as early as 1993 the company had begun taking a wide variety of precautions to avoid heat stress in its workers, from starting their shifts very early in the morning to providing them with many gallons of drinking water per day.

Associated Press reporters saw workers bringing water bottles from their homes, which they refilled during the day from large cylinders of water in the buses that bring them to the fields.

Glaser, the co-founder of the activist group in Nicaragua, La Isla Foundation, said that nonetheless many worker protections in the region are badly enforced by the companies and government regulators, particularly measures to stop workers with failing kidneys from working in the cane fields owned by the Pellas Group and other companies.

Many workers disqualified by tests showing high levels of creatinine go back to work in the fields for subcontractors with less stringent standards, he said. Some use false IDs, or give their IDs to their healthy sons, who then pass the tests and go work in the cane fields, damaging their kidneys.

“This is the only job in town,” Glaser said. “It’s all they’re trained to do. It’s all they know.”

The Ingenio San Antonio mill processes cane from more than 24,000 hectares (60,000 acres) of fields, about half directly owned by the mill and most of the rest by independent farmers.

The trade group for Nicaragua’s sugar companies said the Boston University study had confirmed that “the agricultural sugar industry in Nicaragua has no responsibility whatsoever for chronic renal insufficiency in Nicaragua” because the research found that “in the current body of scientific knowledge there is no way to establish a direct link between sugar cane cultivation and renal insufficiency.”

Brooks, the epidemiologist at Boston University, told the AP that the study simply said there was no definitive scientific proof of the cause, but that all possible connections remained open to future research.

In comparison with Nicaragua, where thousands of kidney disease sufferers work for large sugar estates, in El Salvador many of them are independent small farmers. They blame agricultural chemicals and few appear to have significantly changed their work habits in response to the latest research, which has not received significant publicity in El Salvador.

In Nicaragua, the dangers are better known, but still, workers need jobs. Zapata Palacios left eight children. Three of them work in the cane fields.

Two already show signs of disease.

OMS: Crianças vacinadas contra H1N1 sofrem Narcolepsia

Casos de Narcolepsia foram registados em 12 países em pacientes que recentemente tinham recebido a vacina Pandemrix.

Por Luis R. Miranda
The Real Agenda
Fevereiro 9, 2011

Segundo a OMS, as pessoas afetadas são crianças e adolescentes, mas é necessária mais investigação para determinar com um 100 por cento de certeza que a causa da Narcolepsia é o uso da vacina.

A OMS doou 36 milhões de doses de 'Pandemrix' a 18 países em desenvolvimento.

A Organização Mundial da Saúde (OMS) anunciou nesta terça-feira que pelo menos 12 países relataram casos de narcolepsia em crianças e adolescentes que já haviam sido vacinados contra a gripe A.

O Comité Global de Consulta para a Segurança das Vacinas da OMS publicou uma declaração especificando que “desde Agosto de 2010, após a vacinação em massa contra o vírus da gripe AH1N1 em 2009, houve casos de Narcolepsia em crianças e adolescentes em pelo menos 12 países. ”

No entanto, o grupo afirmou que é preciso “mais pesquisas” para determinar a relação exata entre os casos de Narcolepsia e vacinação contra a gripe, com o produto Pandemrix ou outras vacinas.

Na semana passada, a OMS anunciou que estava investigando um aumento de casos de Narcolepsia, na Finlândia, que poderiam estar associados com a vacina ‘Pandemrix’ fabricada pela empresa GlaxoSmithKline, uma vez que todos os envolvidos parecem ter sido imunizada com o mesmo produto.
Finlândia descontinua o uso da vacina

O Governo da Finlândia tinha relatado casos de Narcolepsia entre os vacinados contra a gripe, todos eles com idades entre 4 e 19 anos.

Em Helsínquia, o Instituto Nacional de Saúde e Bem-Estar da Finlândia (THL) publicou um estudo mostrando que a vacina da gripe H1N1 Pandemrix, fabricada pela empresa farmacêutica GlaxoSmithKline, multiplica o risco de narcolepsia durante a infância.

Segundo este estudo, entre 2009 e 2010 foram diagnosticados 60 casos de Narcolepsia em crianças finlandesas e adolescentes entre 4 e 19 anos, dos quais 52 (quase 90 por cento) haviam sido vacinadas com Pandemrix.

O fenômeno levou as autoridades de saúde finlandês a parar de usar a vacina como medida preventiva, para determinar seus possíveis efeitos colaterais.

A Narcolepsia é um estado patológico que faz com que o paciente sinta uma vontade de dormir irresistível a qualquer momento.

Possíveis países afetados

A OMS que doou 36 milhões de doses da vacina ‘Pandemrix’ a 18 países, três deles latinos, mas até agora não ouviu falar de casos de Narcolepsia.

A lista de países que receberam ‘Pandemrix’ é a seguinte: Arménia, Azerbaijão, Bangladesh, Bolívia, Burkina Fasso, Cuba, Coréia do Norte, El Salvador, Etiópia, Gana, Namíbia, Filipinas, Tadjiquistão, Togo, Ruanda, Quênia, Mongólia e Senegal.

O relatório de conclusão final sobre a relação entre narcolepsia e esta vacina vai ser divulgado em 31 de agosto.

Children Vaccinated against AH1N1 suffer from Narcolepsy

The World Health Organization reports that cases of Narcolepsy are possibly related to the vaccine Pandemrix

by Luis R. Miranda
The Real Agenda
February 8, 2011

The World Health Organization (WHO) announced on Tuesday that at least 12 countries reported cases of narcolepsy in children and adolescents who had previously been vaccinated against influenza AH1N1.

Pandemrix is produced by GlaxoSmithKline

The Global Advisory Committee on Vaccine Safety, WHO has published a statement specifying that “since August 2010, following massive vaccination against influenza virus H1N1 in 2009, there were cases of narcolepsy in children and adolescents in at least 12 countries. ”

However, the group has said it takes “more research” to determine the exact relationship between cases of narcolepsy and influenza vaccination, through the use of the vaccine Pandemrix or another one.

Last week, the WHO announced it was investigating a rise in cases of narcolepsy in Finland which could be associated with the vaccine ‘Pandemrix’ manufactured by GlaxoSmithKline, since all patients seemed to have been immunized with the same product.

Finland discontinued use of the vaccine

The Government of Finland had reported cases of narcolepsy among people ages 4 -19 years old, vaccinated against influenza AH1N1.

In Helsinki, the National Institute of Health and Welfare of Finland (THL) published a study showing that the H1N1 flu vaccine Pandemrix, manufactured by pharmaceutical company GlaxoSmithKline, increases the risk of childhood narcolepsy.

Since August 2010, following massive vaccination against influenza virus H1N1 in 2009, there were cases of narcolepsy in children and adolescents in at least 12 countries, "WHO says

According to this study, between 2009 and 2010 authorities diagnosed 60 cases of narcolepsy in Finnish children and adolescents between 4 and 19 years, of which 52 (almost 90 per cent) had been vaccinated with Pandemrix.

The phenomenon led the Finnish health authorities to stop using this vaccine as a preventive measure to determine the possible side effects.

Narcolepsy is a pathological state that causes the patients to suffer irresistible sleep at any time.

Possible affected countries

The WHO has donated 36 million doses of the vaccine ‘Pandemrix’ to 18 countries. Three of those countries are Latin American ones, but so far non of those nations have reported cases of narcolepsy.

The list of countries that received ‘Pandemrix’ includes: Armenia, Azerbaijan, Bangladesh, Bolivia, Burkina Faso, Cuba, North Korea, El Salvador, Ethiopia, Ghana, Namibia, Philippines, Tajikistan, Togo, Rwanda, Kenya, Mongolia and Senegal.

The completed final report on the relationship between narcolepsy and this vaccine will be published on August 31.


OMS: Niños vacunados contra H1N1 sufren de narcolepsia

Registrados en 12 países casos de narcolepsia con la vacuna de la gripe A

Terra.es

Según la OMS, los afectados son niños y adolescentes, pero hace falta más investigación para determinar que la causa sea la ingesta del medicamento.

La OMS donó 36 millones de dosis de 'Pandemrix' a 18 países en desarrollo.

 

La Organización Mundial de la Salud (OMS) ha anunciado este martes que al menos 12 países registraron casos de narcolepsia en niños y adolescentes que previamente habían sido vacunados contra la gripe A.

El Comité Consultivo Mundial de la Seguridad de Vacunas de la OMS ha publicado un comunicado en el que especifica que “desde agosto de 2010, y tras masivas vacunaciones contra el virus de la gripe H1N1 en 2009, se detectaron casos de narcolepsia en niños y adolescentes en al menos 12 países”.

No obstante, el grupo ha señalado que hace falta “más investigación” para determinar la relación exacta entre los casos de narcolepsia y la vacunación contra la gripe, sea con la vacuna Pandemrix o con otra.

La semana pasada, la OMS anunció que investigaba un aumento de casos de narcolepsia en Finlandia que podría tener relación con la vacuna ‘Pandemrix’ del fabricante Glaxo, dado que todos los afectados parecían haber sido inmunizados con el mismo producto.

Finlandia interrumpe el uso de la vacuna

El Gobierno de Finlandia había informado de casos de narcolepsia entre vacunados contra la gripe A de entre 4 y 19 años.

 

Las autoridades de Finlandia han suspendido el uso de la vacuna, tras detectar varios casos de afectados de entre 4 y 19 años.

En Helsinki, el Instituto Nacional de Salud y Bienestar de Finlandia (THL) publicó un estudio según el cual la vacuna contra la gripe AH1N1 Pandemrix, fabricada por la compañía farmacéutica GlaxoSmithKline, multiplica el riesgo de contraer narcolepsia infantil. 

Según ese estudio, entre 2009 y 2010 se diagnosticaron 60 casos de narcolepsia en niños y adolescentes finlandeses de entre 4 y 19 años, de los cuales 52 (casi el 90 por ciento) habían sido vacunados con Pandemrix.

El fenómeno llevó a las autoridades sanitarias finlandesas a interrumpir el uso de esta vacuna de forma preventiva hasta determinar sus posibles efectos secundarios.

La narcolepsia es un estado patológico que produce en el afectado accesos irresistibles de sueño en cualquier momento.

Posibles países afectados

La OMS ha donado 36 millones de dosis de la vacuna ‘Pandemrix’ a 18 países en desarrollo, tres de ellos latinoamericanos, pero hasta el momento no se han tenido noticias de que se hayan dado casos de narcolepsia.

La lista de países que recibieron ‘Pandemrix’ es la siguiente: Armenia, Azerbaiyán, Bangladesh, Bolivia, Burkina Faso, Cuba, Corea del Norte, El Salvador, Etiopía, Ghana, Namibia, Filipinas, Tayikistán, Togo, Ruanda, Kenia, Mongolia y Senegal.

El informe completo y definitivo sobre la relación entre la narcolepsia y esta vacuna se difundirá el próximo 31 de agosto próximo.